Abstract
Event-free survival (EFS) of newly diagnosed patients with B-Precursor was reviewed. Very high risk patients who might be eligible for a clinical trial that included bone marrow transplant were defined. We conclude that such studies are feasible, provided that problems of informed consent and imperfect HLA matches can be overcome.
Original language | English (US) |
---|---|
Pages (from-to) | 101-107 |
Number of pages | 7 |
Journal | Cancer Research Therapy and Control |
Volume | 9 |
Issue number | 1-2 |
State | Published - 1999 |
Externally published | Yes |
Keywords
- Acute lymphocytic leukemia of childhood
- B-Precursor bone marrow transplant
- Clinical trial
- HLA match
- High risk
ASJC Scopus subject areas
- Oncology
- Cancer Research